Pharmacokinetics of Suvorexant in Participants With Hepatic Insufficiency (MK-4305-017)

NCT01043926 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia
Hepatic Insufficiency

Interventions

DRUG: Suvorexant

Sponsor

Merck Sharp & Dohme LLC